Pharmacovigilance in the Real World. - National Genomics Data Center (CNCB-NGDC)

Advanced Search

Pharmacovigilance in the Real World.

William D Leslie, John T Schousboe

Author Information

William D Leslie: University of Manitoba, Winnipeg, Manitoba, Canada (W.D.L.).
John T Schousboe: Park Nicollet Clinic and HealthPartners Institute, Bloomington, Minnesota, and University of Minnesota, Minneapolis, Minnesota (J.T.S.).

PMID: 30597488 DOI: 10.7326/M18-3550

No abstract text available.

Adverse Drug Reaction Reporting Systems

Canagliflozin

Cohort Studies

Pharmacovigilance

Canagliflozin

Editorial Comment

Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS).Hemorrhagic events associated with tacrolimus: a real-world pharmacovigilance study.Post-marketing safety of panitumumab: a real-world pharmacovigilance study.Real world pharmacovigilance assessment of drug related macular degeneration risks.Safety assessment of selinexor: a real-world pharmacovigilance study.Postmarketing Safety Concerns of Teprotumumab: A Real-World Pharmacovigilance Assessment.Quetiapine is associated with pancreatitis: A real-world pharmacovigilance study.A real-world pharmacovigilance study of esketamine nasal spray.Pharmacovigilance bolstered in the Arab world.Safety of daratumumab in the real-world: a pharmacovigilance study based on FAERS database.

Editorial: Advances in drug-induced diseases.Real-Life Active Surveillance of a Naphazoline/ Hypromellose Fixed Combination's Safety Profile in Peruvian Population.Machine Learning in Causal Inference: Application in Pharmacovigilance.